5AM Venture Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.2M Hold
4,056,379
14.21% 2
2025
Q4
$41.7M Sell
4,056,379
-200,000
-5% -$1.69M 13.11% 1
2025
Q3
$24.7M Sell
4,256,379
-52,000
-1% -$304K 9.04% 2
2025
Q2
$29M Sell
4,308,379
-100,000
-2% -$805K 11.13% 2
2025
Q1
$39.9M Hold
4,408,379
15.07% 1
2024
Q4
$76.2M Hold
4,408,379
18.19% 1
2024
Q3
$70.4M Hold
4,408,379
14.55% 1
2024
Q2
$62.8M Hold
4,408,379
14.05% 2
2024
Q1
$62.5M Hold
4,408,379
13.99% 2
2023
Q4
$66.5M Hold
4,408,379
17.65% 2
2023
Q3
$69.7M Hold
4,408,379
20.04% 2
2023
Q2
$66.7M Hold
4,408,379
16.63% 2
2023
Q1
$63.9M Hold
4,408,379
16.35% 2
2022
Q4
$59.6M Hold
4,408,379
16.02% 2
2022
Q3
$69.5M Hold
4,408,379
13.31% 2
2022
Q2
$53.7M Hold
4,408,379
13.28% 2
2022
Q1
$41.4M Hold
4,408,379
9.04% 3
2021
Q4
$75.5M Buy
+4,408,379
New +$107M 14.17% 2

Other funds holding TRDA